X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 65 filers reported holding X4 PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $14 | -96.8% | 13,280 | -94.1% | 0.00% | – |
Q2 2023 | $439 | +1467.9% | 226,566 | +591.0% | 0.00% | – |
Q1 2023 | $28 | +55.6% | 32,788 | +78.9% | 0.00% | – |
Q4 2022 | $18 | -99.9% | 18,324 | +63.1% | 0.00% | – |
Q3 2022 | $19,000 | -69.4% | 11,237 | -68.5% | 0.00% | – |
Q1 2022 | $62,000 | +416.7% | 35,673 | +571.9% | 0.00% | – |
Q4 2021 | $12,000 | – | 5,309 | +9917.0% | 0.00% | – |
Q3 2021 | $0 | – | 53 | 0.0% | 0.00% | – |
Q2 2021 | $0 | – | 53 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |